Vaxxinity IncNASDAQ:VAXX
- LAST PRICE1.8200
- TODAY'S CHANGE (%)0.0200 (1.1111%)
- Bid / Lots1.8000/ 2
- Ask / Lots1.8300/ 3
- Open / Previous Close1.8000 / 1.8000
- Day Range
- 52 Week Range
- Volume69,971
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VAXX |
|---|---|---|
| 09:32 ET | 3715 | 1.81 |
| 09:34 ET | 4028 | 1.8 |
| 09:38 ET | 734 | 1.8 |
| 09:41 ET | 100 | 1.8 |
| 09:48 ET | 874 | 1.8 |
| 09:54 ET | 286 | 1.825 |
| 09:56 ET | 2449 | 1.79 |
| 09:57 ET | 10100 | 1.795 |
| 09:59 ET | 236 | 1.775 |
| 10:01 ET | 240 | 1.775 |
| 10:03 ET | 110 | 1.7836 |
| 10:06 ET | 251 | 1.7895 |
| 10:08 ET | 100 | 1.775 |
| 10:10 ET | 240 | 1.77 |
| 10:14 ET | 100 | 1.76 |
| 10:15 ET | 1945 | 1.78 |
| 10:17 ET | 200 | 1.77 |
| 10:26 ET | 100 | 1.79 |
| 10:28 ET | 1000 | 1.7888 |
| 10:30 ET | 932 | 1.78 |
| 10:33 ET | 100 | 1.76 |
| 10:35 ET | 5000 | 1.7699 |
| 10:39 ET | 1100 | 1.79 |
| 10:42 ET | 100 | 1.77 |
| 10:46 ET | 820 | 1.79 |
| 10:51 ET | 3508 | 1.8 |
| 10:57 ET | 100 | 1.785 |
| 11:00 ET | 100 | 1.785 |
| 11:06 ET | 286 | 1.7999 |
| 11:09 ET | 6296 | 1.8 |
| 11:18 ET | 556 | 1.8252 |
| 11:24 ET | 700 | 1.81 |
| 11:29 ET | 2052 | 1.8 |
| 11:36 ET | 300 | 1.8 |
| 11:44 ET | 546 | 1.79 |
| 11:49 ET | 100 | 1.79 |
| 11:54 ET | 800 | 1.8 |
| 12:02 ET | 100 | 1.8 |
| 12:14 ET | 100 | 1.8 |
| 12:16 ET | 200 | 1.8 |
| 12:34 ET | 200 | 1.8 |
| 12:38 ET | 1800 | 1.8 |
| 12:39 ET | 100 | 1.8 |
| 12:41 ET | 7048 | 1.8 |
| 12:52 ET | 1857 | 1.81 |
| 01:03 ET | 200 | 1.81 |
| 01:06 ET | 400 | 1.82 |
May 9, 2023
BRIEF-Vaxxinity Reports Q1 Financial Results, from 8:13AM ET on Tuesday May 09, 2023 by Thomson Reuters
8:13AM ET on Tuesday May 09, 2023 by Thomson ReutersVaxxinity Reports First Quarter 2023 Financial Results and Provides Corporate Update, from 8:00AM ET on Tuesday May 09, 2023 by GlobeNewswire
8:00AM ET on Tuesday May 09, 2023 by GlobeNewswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Vaxxinity Inc | 227.8M | -3.0x | --- |
BioVie Inc | 227.5M | -3.4x | --- |
Oric Pharmaceuticals Inc | 226.8M | -2.3x | --- |
Quantum-Si Inc | 230.6M | -1.9x | --- |
Nkarta Inc | 222.7M | -1.9x | --- |
Celcuity Inc | 236.2M | -4.0x | --- |
Company Information
Vaxxinity, Inc. is a biotechnology company. The Company is engaged in the development of rationally designed prophylactic and therapeutic vaccines to combat chronic disorders and infectious diseases with large patient populations and unmet medical needs. The Company’s synthetic peptide vaccine platform (Vaxxine Platform) has enabled the innovation of pipeline candidates designed to bring the efficiency of vaccines to the treatment of chronic diseases, including Alzheimers, Parkinsons, migraine, and hypercholesterolemia. Its pipeline consists of six programs, which include UB-311, UB-312, VXX-301, UB-313, VXX-401 and UB-612. Its UB-311 targets toxic forms of aggregated amyloid-b (Ab) in the brain to fight AD. Its UB-312 targets toxic forms of aggregated a-synuclein in the brain to fight PD and other synucleinopathies, such as Lewy body dementia (LBD) and multiple system atrophy (MSA). Its UB-313 targets Calcitonin Gene-Related Peptide (CGRP) to fight migraines.
Contact Information
- Headquarters
- 1717 Main Street, Suite 3388DALLAS, TX, United States 75201
- Phone
- 254-244-5739
- Fax
- 302-636-5454
Executives
- Executive Chairman
- Louis Reese
- President, Chief Executive Officer, Co-Founder, Director
- Mei Mei Hu
- Senior Vice President - Finance and Accounting
- Jason Pesile
- Chief Scientific Officer
- Farshad Guirakhoo
- General Counsel, Company Secretary
- Rene Paula
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $227.8M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 126.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.60 |
Book Value | $0.49 |
P/E Ratio | -3.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
